THU-177-YI Patient-reported outcomes in primary sclerosing cholangitis: an australian multicentre cohort perspective
Natassia Tan(The Alfred Hospital), Ammar Majeed(Monash University), Nicholas Hannah(The Royal Melbourne Hospital), Kate D. Lynch(Royal Adelaide Hospital), Christopher Zampogna(Eastern Health), Rohit Sawhney(Eastern Health), John Lubel(Eastern Health), Siddharth Sood(The University of Melbourne), Andrew Coulshed(Royal Prince Alfred Hospital), Stephen Bloom, Stuart Roberts, Ken Liu, Avik Majumdar(The University of Melbourne), William Kemp(Monash University), Kate Collins(Austin Health)
Cited by 0
Related Papers
O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress
|Journal of Hepatology|2017|151
Obeticholic acid—a new therapy in PBC and NASH
|British Medical Bulletin|2020|123
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System
|Hepatology|2018|106
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
|Clinical Gastroenterology and Hepatology|2019|104
Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis
|Journal of Crohn s and Colitis|2020|55